Renal cell carcinoma with fibromyomatous stroma: Difference between revisions

Jump to navigation Jump to search
Michael (talk | contribs)
No edit summary
Michael (talk | contribs)
No edit summary
 
(13 intermediate revisions by the same user not shown)
Line 1: Line 1:
'''Renal cell carcinoma with fibromyomatous stroma''', abbreviated '''RCC FMS''', is an evolving subtype of [[renal cell carcinoma]].<ref>{{cite journal |authors=Trpkov K, Williamson SR, Gill AJ, Adeniran AJ, Agaimy A, Alaghehbandan R, Amin MB, Argani P, Chen YB, Cheng L, Epstein JI, Cheville JC, Comperat E, da Cunha IW, Gordetsky JB, Gupta S, He H, Hirsch MS, Humphrey PA, Kapur P, Kojima F, Lopez JI, Maclean F, Magi-Galluzzi C, McKenney JK, Mehra R, Menon S, Netto GJ, Przybycin CG, Rao P, Rao Q, Reuter VE, Saleeb RM, Shah RB, Smith SC, Tickoo S, Tretiakova MS, True L, Verkarre V, Wobker SE, Zhou M, Hes O |title=Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia |journal=Mod Pathol |volume=34 |issue=6 |pages=1167–1184 |date=June 2021 |pmid=33526874 |doi=10.1038/s41379-021-00737-6 |url=}}</ref>
'''Renal cell carcinoma with fibromyomatous stroma''', abbreviated '''RCC FMS''', is an evolving subtype of [[renal cell carcinoma]].<ref>{{cite journal |authors=Trpkov K, Williamson SR, Gill AJ, Adeniran AJ, Agaimy A, Alaghehbandan R, Amin MB, Argani P, Chen YB, Cheng L, Epstein JI, Cheville JC, Comperat E, da Cunha IW, Gordetsky JB, Gupta S, He H, Hirsch MS, Humphrey PA, Kapur P, Kojima F, Lopez JI, Maclean F, Magi-Galluzzi C, McKenney JK, Mehra R, Menon S, Netto GJ, Przybycin CG, Rao P, Rao Q, Reuter VE, Saleeb RM, Shah RB, Smith SC, Tickoo S, Tretiakova MS, True L, Verkarre V, Wobker SE, Zhou M, Hes O |title=Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia |journal=Mod Pathol |volume=34 |issue=6 |pages=1167–1184 |date=June 2021 |pmid=33526874 |doi=10.1038/s41379-021-00737-6 |url=}}</ref>
''Renal cell carcinoma with leiomyomatous stroma'' redirects here.
==General==
*Rare tumour: 12 in >500 renal cell carcinomas with clear cells.<ref name=pmid36592877/>


==Microscopic==
==Microscopic==
Features:
Features:<ref name=pmid36592877>{{cite journal |authors=Tjota MY, Sharma A, Wanjari P, Fitzpatrick C, Segal J, Antic T |title=TSC/MTOR mutated renal cell carcinoma with leiomyomatous stroma is a distinct entity: a comprehensive study of 12 cases |journal=Hum Pathol |volume=134 |issue= |pages=124–133 |date=April 2023 |pmid=36592877 |doi=10.1016/j.humpath.2022.12.015 |url=}}</ref>
*Fibromyomatous stroma - '''key feature'''.
*Fibromyomatous stroma (smooth muscle stroma) - '''key feature'''.
*Varied architecture: nested, solid, tubular, tubulopapillary.
*WHO/ISUP grade 3 or 4.
*Nuclei ''not'' polarized in the cell.


DDx:
DDx:
Line 11: Line 19:


==IHC==
==IHC==
Features:<ref name=pmid36592877/>
*CD10 +ve.
*CK7 +ve (most).
*CA9 +ve.
===Comparison between some renal tumours with clear cells===
===Comparison between some renal tumours with clear cells===
{| class="wikitable sortable"  
{| class="wikitable sortable"  
!Tumour
!Tumour
!CA9
!CK7
!CK7
!CD10
!CD10
!CK34betaE12 (K903)
!CK34betaE12 (K903)
!GPNMB
![[GPNMB]]
|-
|-
|Clear cell renal cell carcinoma  
|Clear cell renal cell carcinoma  
| +ve box-like (complete membrane)
| -ve (may be focal)
| -ve (may be focal)
| +ve
| +ve
Line 26: Line 41:
|-
|-
|Clear cell papillary renal cell tumour  
|Clear cell papillary renal cell tumour  
| +ve cup-like
| +ve (diffuse)
| +ve (diffuse)
| -ve
| -ve
Line 31: Line 47:
| -ve<ref name=pmid37661807>{{cite journal |authors=Li H, Argani P, Halper-Stromberg E, Lotan TL, Merino MJ, Reuter VE, Matoso A |title=Positive GPNMB Immunostaining Differentiates Renal Cell Carcinoma With Fibromyomatous Stroma Associated With TSC1/2/MTOR Alterations From Others |journal=Am J Surg Pathol |volume=47 |issue=11 |pages=1267–1273 |date=November 2023 |pmid=37661807 |doi=10.1097/PAS.0000000000002117 |url=}}</ref>
| -ve<ref name=pmid37661807>{{cite journal |authors=Li H, Argani P, Halper-Stromberg E, Lotan TL, Merino MJ, Reuter VE, Matoso A |title=Positive GPNMB Immunostaining Differentiates Renal Cell Carcinoma With Fibromyomatous Stroma Associated With TSC1/2/MTOR Alterations From Others |journal=Am J Surg Pathol |volume=47 |issue=11 |pages=1267–1273 |date=November 2023 |pmid=37661807 |doi=10.1097/PAS.0000000000002117 |url=}}</ref>
|-
|-
|ELOC-mutated renal cell carcinoma
|ELOC-mutated renal cell carcinoma
| +ve box-like
| +ve
| +ve
| +ve
| +ve
Line 37: Line 54:
| -ve
| -ve
|-
|-
|TSC/mTOR-mutated renal cell carcinoma
|Renal cell carcinoma with fibromyomatous stroma
| +ve box-like or cup-like<ref name=pmid36611378>{{cite journal |authors=Stanca S, Boldrini L, Erba PA, Faviana P |title=Are Renal Cell Carcinoma with Fibromyomatous Stroma (RCC-FMS) and Thyroid-like Follicular Carcinoma of the Kidney (TLFCK) Really Independent Variants? |journal=Diagnostics (Basel) |volume=13 |issue=1 |pages= |date=December 2022 |pmid=36611378 |pmc=9818596 |doi=10.3390/diagnostics13010086 |url=}}</ref>
| +ve
| +ve
| +ve
| +ve
Line 45: Line 63:
|}
|}


==Molecular==
*[[Renal neoplasms with TSC/mTOR pathway mutations|TSC/mTOR pathway mutation]].<ref name=pmid36592877/>
**A somewhat non-specific finding as [[Renal neoplasms with TSC/mTOR pathway mutations|several renal tumours (with a different morphology) have TSC/mTOR pathway mutations]].
==Sign out==
===Molecular lacking===
<pre>
Right Kidney, Radical Nephrectomy:
    - RENAL CELL CARCINOMA with clear cells, cysts and leiomyomatous stroma, see comment.
    -- Margin clear.
    -- Please see synoptic report for details.
Comment:
The tumour stains as follows:
POSITIVE: CD10 (moderate), EMA (patchy), CK7 (diffuse), PAX8 (diffuse).
NEGATIVE: CK34betaE12, CK20.
The differential diagnosis includes: (1) clear cell renal cell carcinoma, (2) RCC with a mTOR pathway mutation, and (3) ELOC-mutated RCC.
</pre>


==See also==
==See also==
*[[Renal cell carcinoma]].
*[[Renal cell carcinoma]].
*[[Clear cells in the kidney]].


==References==
==References==